Market Overview:
The global platelet aggregation system market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for dual-channel, four-channel, and eight-channel platelet aggregation systems in research applications, clinical applications, cardiovascular applications, orthopedic applications, and others. North America is expected to dominate the global platelet aggregation system market during the forecast period owing to the presence of major players in this region and rising demand for advanced medical devices.
Product Definition:
A platelet aggregation system is a device used to measure the ability of platelets to clump together. The importance of platelet aggregation system is that it can help doctors diagnose and treat medical conditions related to abnormal clotting.
Dual-Channel:
Dual-channel technology is a method of increasing the surface area of the platelets by separating them with an agarose plug. The plug allows for better adhesion and increases their ability to aggregate, which leads to increased blood clotting. This technology has been around for quite some time; however, it has gained popularity in recent years due to its use in hemostasis procedures along with ongoing research on its usage as a drug delivery system.
Four-Channel:
The four-channel system is a method of measuring platelet aggregation using different techniques such as ADP fluorescence, flow cytometry, surface plasmon resonance and chemiluminescence. The use of these methods allows for the quantification and analysis of various processes involved in platelet activation from simple adhesion to complex thrombus formation.
This technology has been used extensively in recent years owing to its high sensitivity, accuracy.
Application Insights:
The clinical applications segment held the largest share of over 60.0% in 2017. Platelet aggregation tests are used for diagnosing coagulation disorders, such as hemophilia andvon Willebrand disease. The research applications segment is expected to witness the fastest growth during the forecast period owing to increasing R&D activities pertaining to platelet adhesion and blood clotting mechanisms.
Furthermore, growing prevalence of cardiovascular diseases (CVDs) worldwide coupled with rising geriatric population is anticipated to boost product demand in this segment over the forecast period. According to a study published by World Health Organization (WHO) in 2014, it was estimated that around 1 billion people suffer from CVD globally; however, only half a million die due these diseases every year worldwide thus indicating a huge unmet medical need regarding diagnosis of CVDs which may propel demand for products used in diagnostic procedures related thereto globally during future years.
Regional Analysis:
North America platelet aggregation systems market dominated the global arena in 2017. This can be attributed to the presence of key players such as Abbott, Inc.; Medtronic; and St. Jude Medical, which are engaged in extensive R&D activities for developing novel products for cardiovascular diseases and orthopedic disorders respectively.
In addition to this, growing awareness among people about early diagnosis of life-threatening conditions is expected to fuel regional growth over the forecast period.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive surgeries
- Technological advancements in platelet aggregation systems
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Platelet Aggregation System Market Research Report
By Type
Dual-Channel, Four-Channel, Eight-Channel
By Application
Research Applications, Clinical Applications, Cardiovascular Applications, Orthopedic Applications, Others
By Companies
Haemonetics Corporation (US), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (US), Helena Laboratories Corporation (US), Bio/Data Corporation (US), Tem Group (Switzerland), Sentinel CH. S.p.A. (Italy), Aggredyne, Inc. (US), Haemonetics Corporation (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Platelet Aggregation System Market Report Segments:
The global Platelet Aggregation System market is segmented on the basis of:
Types
Dual-Channel, Four-Channel, Eight-Channel
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Applications, Clinical Applications, Cardiovascular Applications, Orthopedic Applications, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Haemonetics Corporation (US)
- Sysmex Corporation (Japan)
- Siemens AG (Germany)
- Accriva Diagnostics (US)
- Helena Laboratories Corporation (US)
- Bio/Data Corporation (US)
- Tem Group (Switzerland)
- Sentinel CH. S.p.A. (Italy)
- Aggredyne, Inc. (US)
- Haemonetics Corporation (US)
Highlights of The Platelet Aggregation System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dual-Channel
- Four-Channel
- Eight-Channel
- By Application:
- Research Applications
- Clinical Applications
- Cardiovascular Applications
- Orthopedic Applications
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Platelet Aggregation System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Platelet Aggregation System (PAS) is a group of proteins that helps platelets stick together and form clots. The PAS helps to prevent blood from flowing out of small wounds.
Some of the major players in the platelet aggregation system market are Haemonetics Corporation (US), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (US), Helena Laboratories Corporation (US), Bio/Data Corporation (US), Tem Group (Switzerland), Sentinel CH. S.p.A. (Italy), Aggredyne, Inc. (US), Haemonetics Corporation (US).
The platelet aggregation system market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Platelet Aggregation System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Platelet Aggregation System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Platelet Aggregation System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Platelet Aggregation System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Platelet Aggregation System Market Size & Forecast, 2020-2028
4.5.1 Platelet Aggregation System Market Size and Y-o-Y Growth
4.5.2 Platelet Aggregation System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dual-Channel
5.2.2 Four-Channel
5.2.3 Eight-Channel
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research Applications
6.2.2 Clinical Applications
6.2.3 Cardiovascular Applications
6.2.4 Orthopedic Applications
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Platelet Aggregation System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Platelet Aggregation System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dual-Channel
9.6.2 Four-Channel
9.6.3 Eight-Channel
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research Applications
9.10.2 Clinical Applications
9.10.3 Cardiovascular Applications
9.10.4 Orthopedic Applications
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dual-Channel
10.6.2 Four-Channel
10.6.3 Eight-Channel
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research Applications
10.10.2 Clinical Applications
10.10.3 Cardiovascular Applications
10.10.4 Orthopedic Applications
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dual-Channel
11.6.2 Four-Channel
11.6.3 Eight-Channel
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research Applications
11.10.2 Clinical Applications
11.10.3 Cardiovascular Applications
11.10.4 Orthopedic Applications
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dual-Channel
12.6.2 Four-Channel
12.6.3 Eight-Channel
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research Applications
12.10.2 Clinical Applications
12.10.3 Cardiovascular Applications
12.10.4 Orthopedic Applications
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dual-Channel
13.6.2 Four-Channel
13.6.3 Eight-Channel
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research Applications
13.10.2 Clinical Applications
13.10.3 Cardiovascular Applications
13.10.4 Orthopedic Applications
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Platelet Aggregation System Market: Competitive Dashboard
14.2 Global Platelet Aggregation System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haemonetics Corporation (US)
14.3.2 Sysmex Corporation (Japan)
14.3.3 Siemens AG (Germany)
14.3.4 Accriva Diagnostics (US)
14.3.5 Helena Laboratories Corporation (US)
14.3.6 Bio/Data Corporation (US)
14.3.7 Tem Group (Switzerland)
14.3.8 Sentinel CH. S.p.A. (Italy)
14.3.9 Aggredyne, Inc. (US)
14.3.10 Haemonetics Corporation (US)
